Page 11 - Diffuse Largeb Cell News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Robbie A. Sharp, born Nov. 3, 1956, passed away May 1, 2021. This is the day the Lord has made, a day for rejoicing, a day to find joy and beauty in the ordinary and familiar as well as the exotic and new. On May 1, I passed into the Heavenly realm as a result of Non-Hodgkin’s Diffuse Large B-Cell Lymphoma. Waiting for me in Heavenly Celebration are my dad and mom, Wayne and Joanne Sharp; grandparents, A.B. and Marie Sharp; Anna Lou and George Blair; Aunt Patsy Sharp; uncle and aunt, Jim and Virginia Pope; special pets, Maxx, Zeke and Lacy Jill.

Bantam Pharmaceutical Appoints Industry Veteran Michael Stocum as President and Chief Executive Officer News provided by Share this article Share this article NEW YORK, April 28, 2021 /PRNewswire/ -- Bantam Pharmaceutical, a drug discovery and development company targeting selective modulation of mitochondrial dynamics in cancer, announced today that it has named Michael Stocum, MS as President and Chief Executive Officer. Mr. Stocum succeeds the founding Chief Executive Officer, Mike Luther, PhD, MBA and will lead the Company's initial clinical development program. Dr. Luther will remain as ...

100+  pipeline drugs in the Diffuse Large B Cell Lymphoma pipeline landscape. It comprises DLBCL pipeline drug profiles, including clinical and non-clinical stage products. It also includes the Diffuse Large B Cell Lymphoma therapeutics assessment by product type, stage, route of administration, and molecule type, and further highlights the inactive DLBCL pipeline products.   Some of the significant Highlights   Several prominent companies such as ADC Therapeutics, BeiGene, Nordic Nanovector, bluebird bio, Celgene, GlaxoSmithKline, AbbVie, Roche and many others are working to assess ch...